• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳香酰胺取代苯并咪唑衍生查尔酮的设计、合成及生物评价。上调蛋白表达的作用。

Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating Protein Expression.

机构信息

Department of Chemistry, Changzhi University, Changzhi, Shanxi 046011, China.

University of Michigan Medical School, Ann Arbor, MI 48109, USA.

出版信息

Molecules. 2020 Mar 5;25(5):1162. doi: 10.3390/molecules25051162.

DOI:10.3390/molecules25051162
PMID:32150865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7179225/
Abstract

A series of benzimidazole-derived chalcones containing aromatic amide substituent were designed and synthesized. All of the chalcone compounds were tested for their in vitro antitumor activity against human cancer cell lines (HCT116, HepG2, A549, and CRL-5908). The antiproliferative activity of compounds , , , , , against HCT116 cells was significantly better than that that of 5-Fluorouracil (IC50: 94.63 µM). The antitumor activity of these compounds showed obvious differences between the wild type HCT116 and mutant HCT116 () cells. A preliminary mechanistic study suggested that these compounds act by upregulating the expression of protein in tumor cells without inhibiting the MDM2- interaction.

摘要

设计并合成了一系列含有芳香酰胺取代基的苯并咪唑类查尔酮。所有的查尔酮化合物都进行了体外抗肿瘤活性测试,针对人癌细胞系(HCT116、HepG2、A549 和 CRL-5908)。化合物 、 、 、 、 对 HCT116 细胞的增殖抑制活性明显优于 5-氟尿嘧啶(IC50:94.63 µM)。这些化合物的抗肿瘤活性在野生型 HCT116 和突变型 HCT116 () 细胞之间表现出明显的差异。初步的机制研究表明,这些化合物通过上调肿瘤细胞中 蛋白的表达来发挥作用,而不抑制 MDM2- 相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c3/7179225/3d8c9e33c300/molecules-25-01162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c3/7179225/334caf82585b/molecules-25-01162-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c3/7179225/74a8b044face/molecules-25-01162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c3/7179225/3d8c9e33c300/molecules-25-01162-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c3/7179225/334caf82585b/molecules-25-01162-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c3/7179225/74a8b044face/molecules-25-01162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2c3/7179225/3d8c9e33c300/molecules-25-01162-g002.jpg

相似文献

1
Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating Protein Expression.芳香酰胺取代苯并咪唑衍生查尔酮的设计、合成及生物评价。上调蛋白表达的作用。
Molecules. 2020 Mar 5;25(5):1162. doi: 10.3390/molecules25051162.
2
Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.新型苯并咪唑-2-取代苯基或吡啶丙基烯酮衍生物的设计、合成及抗肿瘤活性评价。
Eur J Med Chem. 2016 May 23;114:328-36. doi: 10.1016/j.ejmech.2016.03.029. Epub 2016 Mar 12.
3
Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.新型对功能化的4-氧代色烯-3-基查耳酮类化合物作为MDM2抑制剂带有惊人的硼酸部分:合成、细胞毒性评估及模拟研究
Med Chem. 2020;16(2):212-228. doi: 10.2174/1573406415666190531123751.
4
Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives.设计、合成、表征新型 O-取代查尔酮衍生物及其抗癌活性。
Bioorg Med Chem Lett. 2021 Mar 1;35:127827. doi: 10.1016/j.bmcl.2021.127827. Epub 2021 Jan 26.
5
Synthesis and evaluation of novel α-substituted chalcones with potent anti-cancer activities and ability to overcome multidrug resistance.新型α-取代查耳酮的合成与评价及其具有的强大抗癌活性和克服多药耐药性的能力。
Bioorg Chem. 2019 Jun;87:123-135. doi: 10.1016/j.bioorg.2019.03.014. Epub 2019 Mar 7.
6
Synthesis and biological evaluation of indolyl chalcones as antitumor agents.吲哚查耳酮类化合物的合成及抗肿瘤活性评价。
Bioorg Med Chem Lett. 2010 Jul 1;20(13):3916-9. doi: 10.1016/j.bmcl.2010.05.016. Epub 2010 May 13.
7
Antiproliferative activity and p53 upregulation effects of chalcones on human breast cancer cells.查耳酮对人乳腺癌细胞的抗增殖活性和 p53 上调作用。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1093-1099. doi: 10.1080/14756366.2019.1615485.
8
Antiproliferative and pro-apoptotic activities of 2'- and 4'-aminochalcones against tumor canine cells.2' - 和 4' - 氨基查尔酮对肿瘤犬细胞的抗增殖和促凋亡活性。
Eur J Med Chem. 2017 Sep 29;138:884-889. doi: 10.1016/j.ejmech.2017.06.049. Epub 2017 Jun 27.
9
Design, synthesis, molecular docking and biological evaluation of new dithiocarbamates substituted benzimidazole and chalcones as possible chemotherapeutic agents.新型取代苯并咪唑和查耳酮二硫代氨基甲酸盐的设计、合成、分子对接及作为潜在化疗药物的生物学评价。
Bioorg Med Chem Lett. 2012 May 1;22(9):3274-7. doi: 10.1016/j.bmcl.2012.03.018. Epub 2012 Mar 11.
10
Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.新型异恶唑基查尔酮作为潜在抗癌剂的合成与评价
Bioorg Chem. 2014 Jun;54:38-43. doi: 10.1016/j.bioorg.2014.03.004. Epub 2014 Mar 15.

引用本文的文献

1
Synthesis, and antibacterial activities of novel 1,3,4a,9-tetraza-4H-fluoren-2-amines incorporating phenoxy-N-arylacetamide, pyrazole, and 2-(4-(1-phenyl-1H-pyrazol-3-yl)phenoxy)-N-arylacetamide moieties.新型1,3,4a,9-四氮杂-4H-芴-2-胺的合成及其抗菌活性,该新型胺类化合物包含苯氧基-N-芳基乙酰胺、吡唑和2-(4-(1-苯基-1H-吡唑-3-基)苯氧基)-N-芳基乙酰胺部分。
BMC Chem. 2025 Mar 8;19(1):61. doi: 10.1186/s13065-025-01421-5.
2
Chalcones as Promising Antitumor Agents by Targeting the p53 Pathway: An Overview and New Insights in Drug-Likeness.查耳酮类化合物通过靶向 p53 通路作为有前途的抗肿瘤药物:药物相似性的概述和新见解。
Molecules. 2021 Jun 19;26(12):3737. doi: 10.3390/molecules26123737.

本文引用的文献

1
MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development.肌球蛋白轻链 MYL6B 通过促进 MDM2 介导的 p53 降解,从而推动 HCC 的发展。
J Exp Clin Cancer Res. 2018 Feb 13;37(1):28. doi: 10.1186/s13046-018-0693-7.
2
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity.Nutlin-3a与Wip1抑制剂协同诱导p53活性。
Oncotarget. 2016 May 31;7(22):31623-38. doi: 10.18632/oncotarget.9302.
3
Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
新型苯并咪唑-2-取代苯基或吡啶丙基烯酮衍生物的设计、合成及抗肿瘤活性评价。
Eur J Med Chem. 2016 May 23;114:328-36. doi: 10.1016/j.ejmech.2016.03.029. Epub 2016 Mar 12.
4
Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model.在人源化原位乳腺至肺转移模型中,Mdm2调节剂Nutlin-3a增强卡铂介导的DNA损伤
Mol Cancer Ther. 2015 Dec;14(12):2850-63. doi: 10.1158/1535-7163.MCT-15-0237. Epub 2015 Oct 22.
5
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction (MDM2 Inhibitors) in clinical trials for cancer treatment.用于癌症治疗临床试验的MDM2-p53蛋白-蛋白相互作用小分子抑制剂(MDM2抑制剂)。
J Med Chem. 2015 Feb 12;58(3):1038-52. doi: 10.1021/jm501092z. Epub 2014 Nov 14.
6
Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development.RG7112的发现:一种处于临床开发阶段的小分子MDM2抑制剂。
ACS Med Chem Lett. 2013 Apr 2;4(5):466-9. doi: 10.1021/ml4000657. eCollection 2013 May 9.
7
Drugging the p53 pathway: understanding the route to clinical efficacy.靶向 p53 通路:探索通往临床疗效的途径。
Nat Rev Drug Discov. 2014 Mar;13(3):217-36. doi: 10.1038/nrd4236.
8
The war on cancer: are we winning?抗癌之战:我们正在取胜吗?
Tumour Biol. 2013 Jun;34(3):1275-84. doi: 10.1007/s13277-013-0759-2. Epub 2013 Apr 9.
9
Structure-activity relationship and antitumor activity of thio-benzodiazepines as p53-MDM2 protein-protein interaction inhibitors.硫代苯并二氮杂卓作为 p53-MDM2 蛋白-蛋白相互作用抑制剂的构效关系和抗肿瘤活性。
Eur J Med Chem. 2012 Oct;56:10-6. doi: 10.1016/j.ejmech.2012.08.003. Epub 2012 Aug 10.
10
Allele-specific p53 mutant reactivation.等位基因特异性 p53 突变体的重新激活。
Cancer Cell. 2012 May 15;21(5):614-625. doi: 10.1016/j.ccr.2012.03.042.